Scarica l'app Stockscreener
41.61
0.38%
-0.13
Cg Oncology Inc Borsa (CGON) Ultime notizie
CG Oncology (NASDAQ:CGON) Earns Outperform Rating from Analysts at Wedbush - MarketBeat
How Positive Cretostimogene Trial Updates And Leadership Moves At CG Oncology (CGON) Have Changed Its Investment Story - Yahoo Finance
CG Oncology, Inc. (CGON) is a Buy on Cancer Treatment Development: Truist Securities - Insider Monkey
Promising Prospects for CG Oncology, Inc.: Buy Rating Backed by Cretostimogene’s Potential in NMIBC Market - TipRanks
CG Oncology (NASDAQ:CGON) Sets New 1-Year HighStill a Buy? - MarketBeat
Cg Oncology Inc. (CGON) Live Share Price, Invest From India - INDmoney
CG Oncology, Inc. (CGON) stock price, news, quote and history - Yahoo Finance UK
CG Oncology Incannounced topline data from Bond-003 cohort P and first results from Core-008 cohort A - marketscreener.com
New Cretostimogene Grenadenorepvec Data Highlight its Potential to Become the Backbone Therapy for High-Risk Non-Muscle Invasive Bladder Cancer - The Manila Times
CG Oncology Reports Promising Efficacy and Safety Data for Cretostimogene in High-Risk Non-Muscle Invasive Bladder Cancer Trials - Quiver Quantitative
CG Oncology (NASDAQ: CGON) posts 83.7% CR, no Grade 3+ AEs in NMIBC trial data - Stock Titan
Schroder Investment Management Group Acquires 155,737 Shares of CG Oncology, Inc. $CGON - MarketBeat
CG Oncology appoints Rossi to its Board of Directors - MSN
Muscle Invasive Bladder Cancer Market to Reach New Heights - openPR.com
Midday Stock Roundup: Tilly’s, indie Semiconductor Up - Orange County Business Journal
CG Oncology (CGON) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
FY2025 EPS Estimates for CG Oncology Increased by Analyst - MarketBeat
A Look at CG Oncology's (CGON) Valuation Following New Clinical Trial Data Announcements - Sahm
Will CG Oncology Inc. stock beat EPS estimatesMarket Sentiment Review & Proven Capital Preservation Tips - BỘ NỘI VỤ
Guidance Update: Will CG Oncology Inc. stock beat EPS estimates2025 Key Lessons & Proven Capital Preservation Tips - moha.gov.vn
Tejara Capital Ltd Purchases New Position in CG Oncology, Inc. $CGON - MarketBeat
Midday Stock Roundup: Eledon Up 4.8% - Orange County Business Journal
Intech Investment Management LLC Acquires 6,503 Shares of CG Oncology, Inc. $CGON - MarketBeat
CG Oncology, Inc. $CGON Shares Purchased by Franklin Resources Inc. - MarketBeat
Geode Capital Management LLC Increases Stake in CG Oncology, Inc. $CGON - MarketBeat
CG Oncology Appoints Christina Rossi to Board - MSN
Why analysts upgrade CG Oncology Inc. stock2025 Analyst Calls & Long-Term Growth Stock Strategies - moha.gov.vn
CG Oncology (NASDAQ:CGON) Reaches New 12-Month HighHere's What Happened - MarketBeat
[Form 4] CG Oncology, Inc. Insider Trading Activity - Stock Titan
[Form 3] CG Oncology, Inc. Initial Statement of Beneficial Ownership - Stock Titan
CG Oncology, Inc. Announces Board and Committee Changes - marketscreener.com
CG Oncology appoints Christina Rossi to board of directors By Investing.com - Investing.com Nigeria
Promising Developments in CG Oncology’s NMIBC Treatment Drive Buy Recommendation - TipRanks
CG Oncology appoints Christina Rossi to board as Simone Song resigns - Investing.com UK
CG Oncology appoints Christina Rossi to board as Simone Song resigns By Investing.com - Investing.com South Africa
CG Oncology appoints Christina Rossi to board of directors - Investing.com India
CG Oncology Announces Board Changes - TradingView
[8-K] CG Oncology, Inc. Reports Material Event | CGON SEC FilingForm 8-K - Stock Titan
CG Oncology Appoints Christina Rossi to Board of Directors - Quiver Quantitative
CG Oncology Announces New Board Member and Board Transition - The Manila Times
CG Oncology (NASDAQ: CGON) names Rossi to board amid BLA initiation - Stock Titan
CG Oncology, Inc. $CGON Position Lifted by Foresite Capital Management V LLC - MarketBeat
CG Oncology (NASDAQ: CGON) highlights BOND-003 and CORE-008 NMIBC data at SUO meeting - Stock Titan
Truist Financial Begins Coverage on CG Oncology (NASDAQ:CGON) - MarketBeat
CG Oncology, Inc. (CGON) Has a New Rating from Truist Financial - The Globe and Mail
CG Oncology Inc Stock Analysis and ForecastVolume Profile Analysis & Explosive Profit Growth - earlytimes.in
TD Cowen Initiates Coverage of CG Oncology (CGON) with Buy Recommendation - MSN
CG Oncology initiated with a Buy at Truist - TipRanks
Truist Securities initiates coverage on CG Oncology stock with Buy rating - Investing.com Canada
CG Oncology price target raised to $61 from $53 at RBC Capital - MSN
Ensign Peak Advisors Inc Has $10.31 Million Stock Holdings in CG Oncology, Inc. $CGON - MarketBeat
How Investors May Respond To CG Oncology (CGON) Leadership Transition Amid Rising Revenue and Expanding Losses - Sahm
15,758 Shares in CG Oncology, Inc. $CGON Bought by Neo Ivy Capital Management - MarketBeat
CenterBook Partners LP Acquires 56,971 Shares of CG Oncology, Inc. $CGON - MarketBeat
0.27%
1.41%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):